2 options
Generic drug industry dynamics / David Reiffen and Michael R. Ward.
- Format:
- Book
- Government document
- Author/Creator:
- Reiffen, David A.
- Series:
- Working paper (United States. Federal Trade Commission. Bureau of Economics) ; no. 248.
- [Working paper ; no. 248]
- Language:
- English
- Subjects (All):
- Generic drugs--Economic aspects--United States.
- Generic drugs.
- Pharmaceutical industry--United States.
- Pharmaceutical industry.
- Drug Industry--economics.
- Drugs, Generic--economics.
- United States.
- Medical Subjects:
- Drug Industry--economics.
- Drugs, Generic--economics.
- United States.
- Physical Description:
- 1 online resource.
- Place of Publication:
- [Washington, D.C.] : [Bureau of Economics, U.S. Federal Trade Commission], [2002]
- Summary:
- This report explores the generic drug industry as a useful laboratory for understanding how competition evolves within a market; exploiting the unique institutional and regulatory features of the generic drug industry to estimate certain structural relationships, including the relationship between price and the number of competitors, and between drug characteristics and the entry process. The report demonstrates how these structural estimates can be used to evaluate recent policy changes toward the pharmaceutical industry.
- Notes:
- Title from PDF title page.
- "February, 2002."
- Includes bibliographical references (pages 37-38).
- Other Format:
- Reiffen David. Generic drug industry dynamics
- OCLC:
- 231631530
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.